Ovarian Neoplasms: all 2,757 studies
Page 5 of 28. Open to participants first (735), then studies with results posted, then the rest; newest registration first within each.
- A Study of Sofe-M in Participants With Selected Advanced Solid TumorsRecruitingNCT06400472Phase 1
- Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian CancerRecruitingNCT06395844Phase 1/2
- A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid MalignanciesRecruitingNCT06395519Phase 1/2
- SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian CancerRecruitingNCT06394492Phase 3
- JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C MutationRecruitingNCT06386146Phase 1/2
- A Phase I/II Trial of UCB4594 in Participants With Advanced CancerRecruitingNCT06380816Phase 1/2
- Fasting Mimicking Diet in Chemotherapy of Gynecologic MalignanciesRecruitingNCT06376604Not applicable
- Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian CancerRecruitingNCT06366490Phase 1
- Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOCRecruitingNCT06341907Phase 2/3
- Mesenteric Infiltration in Ovarian CancerRecruitingNCT06331130
- A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)RecruitingNCT06330064Phase 1/2
- SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell TumoursNot yet recruitingNCT06329323
- Spatial Radiogenomics of Ovarian CancerRecruitingNCT06324175
- Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian CancerRecruitingNCT06321484Phase 1
- Artificial Intelligence Model for Growth Prediction of Ovarian Cancer OrganoidsRecruitingNCT06317610
- To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence and Evaluating Prognosis of Epithelial Ovarian CancerNot yet recruitingNCT06315270
- A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian CancerRecruitingNCT06308406Phase 1/2
- Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T CellsRecruitingNCT06305299Phase 1
- FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLCRecruitingNCT06303505Phase 1/2
- Frailty, Quality Of Life and Early Reversal of Temporary Defunctioning Stoma in Ovarian CancerRecruitingNCT06298877Not applicable
- Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES StudyRecruitingNCT06295965
- Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid TumorsRecruitingNCT06293898Phase 1
- Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive SurgeryRecruitingNCT06290193Phase 2
- The Gynecological Cancer Associated Thrombosis (GynCAT) StudyRecruitingNCT06284343
- Administration of Hyperthermic Intraperitoneal Chemotherapy in the General WardNot yet recruitingNCT06277947Not applicable
- Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid TumorsRecruitingNCT06276491Phase 1
- Tumor Microenvironment in Ovarian CancerRecruitingNCT06272240
- A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid TumorsRecruitingNCT06270706Phase 1
- Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced NeuropathyRecruitingNCT06268665Phase 2
- Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid TumorsRecruitingNCT06256055Phase 1
- Exercise and Nutrition Intervention in Ovarian CancerRecruitingNCT06250686Not applicable
- Liquid Biopsy-based Early Detection of Ovarian Cancer: a Proof-of-concept Study ( PROFOUND-OC )RecruitingNCT06249308
- Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid TumorsRecruitingNCT06243185Phase 2
- A Study of MGC026 in Participants With Advanced Solid TumorsRecruitingNCT06242470Phase 1
- The Correlation Between HRD Detection and the Efficacy of PARP Inhibitors in Ovarian CancerNot yet recruitingNCT06242392
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsRecruitingNCT06239194Phase 1/2
- HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of ChinaNot yet recruitingNCT06238284
- Effect of Early Enteral Nutrition on Postoperative Recovery of Ovarian Cancer PatientsRecruitingNCT06236958
- A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid TumorsRecruitingNCT06234423Phase 1
- Evaluation of 68Ga-FAPI-46 and 18F-FDG PET/CT Imaging for Detecting Recurrent Tumor Lesions in Patients of Ovarian CancerRecruitingNCT06232122Not applicable
- Patients Derived Organoids as a Promising Tool to Tailor Ovarian Cancer Therapies (PANDORA).RecruitingNCT06229522
- SUROVA - Surgery in Ovarian Cancer, Comparing Primary and Interval Cytoreductive SurgeryRecruitingNCT06223763
- Study on Symptom Clusters During Chemotherapy in Ovarian Cancer Patients With Different Chinese Medicine ConstitutionRecruitingNCT06222008
- Evaluation of Amino Acid Metabolism Changes in Ovarian CancerRecruitingNCT06216496Not applicable
- A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian CancerNot yet recruitingNCT06211023Phase 2/3
- NYSCF Scientific Discovery BiobankRecruitingNCT06203106
- Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian CancerNot yet recruitingNCT06188455Phase 3
- Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer PatientsRecruitingNCT06182917
- Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic ProgressionRecruitingNCT06180356Phase 2
- A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsRecruitingNCT06172478Phase 2
- Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPiNot yet recruitingNCT06161272Phase 2
- A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube CancerRecruitingNCT06161025Phase 2/3
- HRD Tests for Ovarian cancERRecruitingNCT06152731Phase 2
- Combined Program of Supervised Physical Exercise and Nutritional Counseling in Ovarian Cancer Patients on Frontline Maintenance Treatment With PARP InhibitorsNot yet recruitingNCT06139783Not applicable
- Transforming Ovarian Cancer Diagnostic PathwaysRecruitingNCT06129968
- Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsRecruitingNCT06128551Phase 1/2
- The Registry of Genetic Alterations of Taiwan Ovarian CancerRecruitingNCT06127446
- Shanghai Ovarian Cancer and Family Care ProjectRecruitingNCT06118307
- Systems Oncology Approach to Optimize Ovarian Cancer TreatmentRecruitingNCT06117384
- Doppler Ultrasound and CT Versus Laparoscopy in Assessment of Ovarian MalignancyRecruitingNCT06109545
- Prospective RegIstration Of the peRformance of the IoTa ADNEX Model in Dutch gYnaecological PracticeRecruitingNCT06103916
- The Efficacy and Safety of Fluzopril Combined With Apatinib in Maintenance Treatment of Platinum Resistant Recurrent Ovarian Cancer PatientsNot yet recruitingNCT06102707Not applicable
- Individualized Health Management of Epithelial Ovarian Cancer: A Retrospective StudyRecruitingNCT06085456
- Patients Derived Organoids in Ovarian CancerRecruitingNCT06085404Not applicable
- Unravelling Tumour Biology In Ovarian Cancer With Precision ImagingRecruitingNCT06084195Not applicable
- Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline TherapyRecruitingNCT06083844Phase 2
- Fluzoparib Combined With Apatinib in Relapsed Ovarian Carcinoma Maintenance TreatmentNot yet recruitingNCT06081595Phase 2
- SEQUENTIAL PROFILING OF TUMOR-DERIVED CIRCULATING CELL-FREE DNA (ctDNA) IN ADVANCED OVARIAN CANCER PATIENTSRecruitingNCT06071286Not applicable
- Investigating Participation Patterns Among Recurrent Ovarian Cancer PatientsNot yet recruitingNCT06070285
- First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian CancerNot yet recruitingNCT06063070Phase 2
- SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian CancerNot yet recruitingNCT06055348Phase 1/2
- A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionRecruitingNCT06051695Phase 1/2
- Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial CancerRecruitingNCT06040970Phase 1/2
- A Real-World Patient-Reported Outcomes Study in Patients With Long-Term Use of NiraparibRecruitingNCT06037213
- Spanish Decision Tool for Ovarian Cancer Maintenance TherapyRecruitingNCT06036810Not applicable
- PRO for Fighting FT in Ovarian CancerRecruitingNCT06032975
- Dynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary TreatmentsRecruitingNCT06025045
- Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total HysterectomyRecruitingNCT06024109
- A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)RecruitingNCT06023862Phase 2
- Study on the Dynamic Changes of Metabolic Biomarkers and Their Prognostic Relationship in Ovarian CancerRecruitingNCT06019923
- A Cohort Establishment Study of Total Management of Ovarian CancerRecruitingNCT06018935
- Predicting Outcome of Cytoreduction in Advanced Ovarian CancerRecruitingNCT06017557Not applicable
- IN10018 in Combination With Pegylated Liposomal Doxorubicin (PLD) vs. Placebo in Combination With PLD for the Treatment of Platinum-resistant Recurrent Ovarian CancerRecruitingNCT06014528Phase 2
- HS-20089 in Patients With Ovarian Cancer and Endometrial CancerRecruitingNCT06014190Phase 2
- A Prospective, Randomized Controlled Study of Cyclophosphamide, Bevacizumab With or Without Envafolimab in Recurrent Epithelial Ovarian Cancer (EOC), Fallopian Tube Cancer, and Primary Peritoneal CancerNot yet recruitingNCT06010667
- Alternate Day Fasting After Surgery for Patients Undergoing ChemotherapyRecruitingNCT05990426Not applicable
- SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi TherapyRecruitingNCT05990192Phase 2
- A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid TumorsRecruitingNCT05989724Phase 1
- Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid TumorsRecruitingNCT05983432Phase 1
- Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian CancerRecruitingNCT05983276Phase 2
- Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian CancerNot yet recruitingNCT05976932
- Prospective Validation of the ADNEX Model for Discrimination Between Benign and Malignant Adnexal Masses in Pregnancy: International Ovarian Tumour Analysis in Pregnancy Study (p-IOTA)RecruitingNCT05974618
- Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsAvailableNCT05974410
- Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom MonitoringRecruitingNCT05974150
- Aribulin Combined With Carboplatin and Bevacizumab in the Treatment of Ovarian CancerNot yet recruitingNCT05965141Phase 1/2
- Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian CancerRecruitingNCT05961124Phase 2
- MIRRORS-RCT Pilot: Role of Robotic Interval Cytoreductive Surgery for Advanced Ovarian CancerRecruitingNCT05960630Not applicable
- Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/PembroRecruitingNCT05952453Phase 2
- CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian CancerRecruitingNCT05942300Phase 1
- A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid TumorsRecruitingNCT05941507Phase 1/2